Skip to main content

Table 2 Clinicopathological characteristics of stage III patients

From: Appraisal of long-time outcomes after curative surgery in elderly patients with gastric cancer: a propensity score matching analysis

  EP group(n = 23) NEP group(n = 25) p value
Age (years) 80.5 ± 4.9 62.2 ± 8.92  < 0.001
Sex 0.075
 Male 21 (91.3) 17 (68.0)  
 Female 2 (8.7) 8 (32.0)  
CCI 0.067
 Low 6 (26.1) 13 (52.0)  
 Moderate/severe 17 (73.9) 12 (48.0)  
mFI 0.087 ± 0.068 0.051 ± 0.058 0.068
Tumor size (mm) 64.1 ± 27.5 69.9 ± 31.2 0.174
Depth of tumor invasion 0.548
 T1 0 0  
 T2 2 (8.7) 2 (8.0)  
 T3 10 (43.5) 14 (56.0)  
 T4 11 (47.8) 9 (36.0)  
Lymph node metastasis 0.845
 N0 0 0  
 N1 2 (8.7) 3 (12.0)  
 N2 11 (47.8) 9 (36.0)  
 N3 10 (43.5) 13 (52.0)  
Histologic type 1.000
 Differentiated 8 (34.8) 8 (32.0)  
 Undifferenciated 15 (65.2) 17 (68.0)  
Lymphatic invasion 0.214
 ly0 0 0  
 ly1 4 (17.4) 3 (12.0)  
 ly2 8 (34.8) 15 (60.0)  
 ly3 11 (47.8) 7 (28.0)  
Venous invasion 0.907
 v0 2 (8.7) 3 (12.0)  
 v1 9 (39.1) 10 (40.0)  
 v2 9 (39.1) 10 (40.0)  
 v3 3 (13.1) 2 (8.0)  
  1. Data are presented as the mean ± standard deviation or number (percentage) of patients
  2. CCI Charlson comorbidity index, EP elderly patient, mFI modified frailty index, NEP non-elderly patient